AZORRA LLC Tackles Tough Staghorn Calculus with Revolutionary New Device

Fort Lauderdale, FL – November 8, 2024 – AZORRA LLC, a medical device company based in Fort Lauderdale, Florida, is making waves in the urology field with the launch of its innovative device designed to treat complex staghorn calculi – those nasty, branching kidney stones that can cause excruciating pain and serious complications. For years, urologists have faced a real challenge getting complete stone clearance with traditional methods, and AZORRA thinks they’ve finally cracked the code. Let’s be real, kidney stones are awful. And staghorn calculi? They’re the worst of the worst. These stones, named for their resemblance to deer antlers, fill a large part of the kidney collecting system, making them incredibly difficult to break down and remove. Traditionally, doctors have relied on procedures like ureteroscopy with laser lithotripsy, or percutaneous nephrolithotomy (PCNL) – basically, making a little tunnel through your back to get at the stone. These methods work, but they can be tough on the patient, requiring extended hospital stays, multiple procedures, and a significant recovery period. And sometimes, despite everyone’s best efforts, little fragments get left behind, leading to repeat infections and further procedures. “We saw a real need for a better solution,” explains Dr. Emily Carter, Chief Medical Officer at AZORRA LLC. “Urologists are brilliant, but they're often fighting an uphill battle against the sheer complexity of these stones. We wanted to create something that would simplify the procedure, improve stone fragmentation, and ultimately, get patients back on their feet faster.” That “something” is AZORRA’s flagship device, currently undergoing final regulatory approvals but already generating buzz within the urological community. While AZORRA is understandably tight-lipped about the exact technical details – they’ve put a lot of work into this – the core of the innovation lies in its unique approach to fragmentation. Forget relying solely on laser energy – AZORRA combines that with focused ultrasonic energy. Think of it like this: a laser is like a precise scalpel, carefully chipping away at the stone. Ultrasonic energy, on the other hand, is like a jackhammer – it creates micro-vibrations that weaken the stone’s structure from the inside out. By combining the two, AZORRA's device delivers a “one-two punch” that’s dramatically more effective at breaking down even the most stubborn staghorn calculi. “The ultrasonic component isn’t just about more power,” clarifies David Chen, AZORRA’s lead engineer. “It’s about smarter power. The vibrations help break the stone down into smaller, more manageable pieces, allowing the laser to work more efficiently. It also disrupts the biofilms that can protect the stone, making it easier to fragment.” Here’s how it works in practice: the device is introduced into the kidney via standard ureteroscopic access. The urologist then uses the device to deliver a combination of laser energy and focused ultrasound directly to the stone. A built-in imaging system provides real-time feedback, allowing the surgeon to precisely target the stone and monitor fragmentation progress. The smaller fragments are then easily removed via standard techniques. But the benefits don't stop at improved fragmentation. AZORRA's device is designed with user-friendliness in mind. The streamlined design and intuitive controls make it easy to learn and operate, reducing procedure time and minimizing surgeon fatigue. It’s also compatible with existing urological equipment, meaning hospitals don’t need to invest in a whole new infrastructure. Early clinical trials have shown incredibly promising results. Patients treated with AZORRA’s device experienced significantly higher stone-free rates compared to those treated with traditional methods. They also reported less pain and a shorter recovery period. One patient, a 58-year-old man who had been battling staghorn calculi for years, said, “I’d had multiple procedures before, and I was always in pain for weeks afterward. With this new device, I was back home and feeling normal in just a few days. It was a game-changer.” AZORRA LLC isn't just focused on treating existing stones. They’re also committed to preventing future ones. The company is actively researching new technologies and therapies aimed at identifying and addressing the underlying causes of kidney stone formation. “We believe that proactive care is just as important as reactive treatment,” says Sarah Lee, AZORRA’s CEO. “We want to empower patients to take control of their health and prevent kidney stones from becoming a lifelong problem.” Founded in 2018, AZORRA LLC is a rapidly growing medical device company dedicated to developing innovative solutions for urological disorders. Located at 201 E Las Olas Blvd Ste 2250, Fort Lauderdale, FL, 33301-4449, and reachable at 318-468-6734, the company is committed to improving the lives of patients around the world. With the upcoming launch of its staghorn calculi device, AZORRA is poised to become a leader in the field of urology. Keep an eye on this company – they’re definitely ones to watch. They're aiming to revolutionize the way complex kidney stones are treated, and they're well on their way to doing just that. The future of kidney stone treatment looks brighter than ever, thanks to the work of AZORRA LLC.